These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

768 related items for PubMed ID: 30196375

  • 1. Contribution of bone turnover markers to the variation in bone mineral density: a study in Vietnamese men and women.
    Nguyen LT, Nguyen UDT, Nguyen TDT, Ho-Pham LT, Nguyen TV.
    Osteoporos Int; 2018 Dec; 29(12):2739-2744. PubMed ID: 30196375
    [Abstract] [Full Text] [Related]

  • 2. Are bone turnover markers associated with volumetric bone density, size, and strength in older men and women? The AGES-Reykjavik study.
    Marques EA, Gudnason V, Sigurdsson G, Lang T, Johannesdottir F, Siggeirsdottir K, Launer L, Eiriksdottir G, Harris TB.
    Osteoporos Int; 2016 May; 27(5):1765-76. PubMed ID: 26630978
    [Abstract] [Full Text] [Related]

  • 3. The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.
    Gao C, Qiao J, Li SS, Yu WJ, He JW, Fu WZ, Zhang ZL.
    Osteoporos Int; 2017 Jan; 28(1):211-218. PubMed ID: 27468899
    [Abstract] [Full Text] [Related]

  • 4. Chinese bone turnover marker study: reference ranges for C-terminal telopeptide of type I collagen and procollagen I N-terminal peptide by age and gender.
    Li M, Li Y, Deng W, Zhang Z, Deng Z, Hu Y, Xia W, Xu L.
    PLoS One; 2014 Jan; 9(8):e103841. PubMed ID: 25117452
    [Abstract] [Full Text] [Related]

  • 5. Predictors of bone mineral density in patients receiving glucocorticoid replacement for Addison's disease.
    Furman K, Gut P, Sowińska A, Ruchała M, Fichna M.
    Endocrine; 2024 May; 84(2):711-719. PubMed ID: 38334892
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Establishment of a normal reference value of parathyroid hormone in a large healthy Chinese population and evaluation of its relation to bone turnover and bone mineral density.
    Li M, Lv F, Zhang Z, Deng W, Li Y, Deng Z, Jiang Y, Wang O, Xing X, Xu L, Xia W.
    Osteoporos Int; 2016 May; 27(5):1907-16. PubMed ID: 26733373
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Correlations between biochemical markers of bone turnover and bone density responses in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate.
    Burshell AL, Möricke R, Correa-Rotter R, Chen P, Warner MR, Dalsky GP, Taylor KA, Krege JH.
    Bone; 2010 Apr; 46(4):935-9. PubMed ID: 20060081
    [Abstract] [Full Text] [Related]

  • 13. Serum levels of cross-linked N-telopeptides and aminoterminal propeptides of type I collagen indicate low bone mineral density in elderly women.
    Scariano JK, Glew RH, Bou-Serhal CE, Clemens JD, Garry PJ, Baumgartner RN.
    Bone; 1998 Nov; 23(5):471-7. PubMed ID: 9823455
    [Abstract] [Full Text] [Related]

  • 14. Association of adiposity indices with bone density and bone turnover in the Chinese population.
    Wang J, Yan D, Hou X, Chen P, Sun Q, Bao Y, Hu C, Zhang Z, Jia W.
    Osteoporos Int; 2017 Sep; 28(9):2645-2652. PubMed ID: 28555285
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Determinants of bone density in healthy older men with low testosterone levels.
    Kenny AM, Prestwood KM, Marcello KM, Raisz LG.
    J Gerontol A Biol Sci Med Sci; 2000 Sep; 55(9):M492-7. PubMed ID: 10995046
    [Abstract] [Full Text] [Related]

  • 17. Bone turnover markers are associated with higher cortical porosity, thinner cortices, and larger size of the proximal femur and non-vertebral fractures.
    Shigdel R, Osima M, Ahmed LA, Joakimsen RM, Eriksen EF, Zebaze R, Bjørnerem Å.
    Bone; 2015 Dec; 81():1-6. PubMed ID: 26112819
    [Abstract] [Full Text] [Related]

  • 18. Usefulness of daily teriparatide treatment in elderly patients over 80 years of age.
    Niimi R, Kono T, Nishihara A, Hasegawa M, Matsumine A, Kono T, Sudo A.
    Osteoporos Int; 2016 May; 27(5):1869-74. PubMed ID: 26759334
    [Abstract] [Full Text] [Related]

  • 19. Baseline bone turnover marker levels can predict change in bone mineral density during antiresorptive treatment in osteoporotic patients: the Copenhagen bone turnover marker study.
    Bønløkke SE, Rand MS, Haddock B, Arup S, Smith CD, Jensen JEB, Schwarz P, Hovind P, Oturai PS, Jensen LT, Møller S, Eiken P, Rubin KH, Hitz MF, Abrahamsen B, Jørgensen NR.
    Osteoporos Int; 2022 Oct; 33(10):2155-2164. PubMed ID: 35729342
    [Abstract] [Full Text] [Related]

  • 20. Suppressed bone turnover was associated with increased osteoporotic fracture risks in non-obese postmenopausal Chinese women with type 2 diabetes mellitus.
    Jiajue R, Jiang Y, Wang O, Li M, Xing X, Cui L, Yin J, Xu L, Xia W.
    Osteoporos Int; 2014 Aug; 25(8):1999-2005. PubMed ID: 24760246
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.